By a News Reporter-Staff News Editor at Drug Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “INIVE” by Jay G. Kolman, Esq., representing Noven Pharmaceuticals. This application was made available to the public on June 30, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 005.
The serial number for this application is 86235646.
As submitted by the applicant, this trademark application relates to the following goods and services: Pharmaceutical preparations, namely contraceptives.
The owner/registrar information for this application is: Jay G. Kolman, Esq., Noven Pharmaceuticals, 11960 Sw 144th St, Miami, FL 33186-6109.
Keywords for this news article include: Noven Pharmaceuticals, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Trademark Application for “INIVE” Filed by Noven Pharmaceuticals
By a News Reporter-Staff News Editor at Drug Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "INIVE" by Jay
- 1 min Read
- 07.9.2014
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
Crush spreads, which have been trending, are barometers of soybean supply and demand and a real-time indicator of processor profitability.
Despite munis’ tax advantages, alternatives' higher yields continue to divert investors who may be wary of interestrate risks.
A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.
Why have three of the most successful men in Silicon Valley decided to branch out from computing and into nuclear energy?
The Fed model compares the return profile of stocks and US government bonds.
